Guodan Bio's IPO

Guodan Bio raised a round of funding on August 22, 2018. Investors include Public.

Guodan Bio (国丹生物) (872960), which is a subsidiary of Guodan Group (国丹集团), engages in the development, production and sales of medicine.…

Articles about Guodan Bio's IPO: